Ricardo Villalon
Santiago, RM, Chile
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The Possible Role of Matrix Metalloprotienase-2 in the Relapse in Patients with Stage II Colon Cancer Treated by Curative Surgery.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: January 19, 2023
Improvement in the Neutrophil-Lymphocyte Ratio after Combined Fluorouracil, Leucovorina and Oxaliplatino based (FOLFOX) Chemotherapy for Stage III Colon Cancer is Associated with Improved Minimal Residual Disease and Outcome.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: November 09, 2021
Improvement in immune dysfunction after FOLFOX chemotherapy for Stage III colon cancer is associated with improved minimal residual disease prognostic subtype and outcome.
Journal: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
Published: March 24, 2021
Immune Dysfunction as Measured by the Systemic Immune-Inflammation Index is Associated with the Sub-Type of Minimal Residual Disease and Outcome in Stage II Colon Cancer Treated with Surgery alone.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: January 13, 2021
The association of the neutrophil-lymphocyte ratio with the presence of minimal residual disease and outcome in patients with Stage II colon cancer treated with surgery alone.
Journal: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
Published: July 21, 2020
Subtypes of minimal residual disease and outcome for stage II colon cancer treated by surgery alone.
Subtypes of minimal residual disease and outcome for stage II colon cancer treated by surgery alone.
Journal: Ecancermedicalscience
Published: March 31, 2020
Effect of FOLFOX on minimal residual disease in Stage III colon cancer and risk of relapse.
Journal: Ecancermedicalscience
Published: February 13, 2019
Secondary Circulating Tumor Cells (CTCs) but not Primary CTCs are Associated with the Clinico-Pathological Parameters in Chilean Patients With Colo-Rectal Cancer.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: June 25, 2015
Muir-Torre syndrome: case report and molecular characterization.
Journal: Sao Paulo medical journal = Revista paulista de medicina
Published: May 03, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026